EDARBYCLOR 12.5 MG
CHLORTHALIDONE : 12.5 MG AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) : 80 MG · DIN 02397757 · BAUSCH HEALTH, CANADA INC.
Health Canada status: DORMANT
What is EDARBYCLOR?
EDARBYCLOR 12.5 MG contains CHLORTHALIDONE : 12.5 MG AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) : 80 MG. It is listed in the Health Canada Drug Product Database under DIN 02397757, held by BAUSCH HEALTH, CANADA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 13-Jul-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02397757 |
|---|---|
| Brand name | EDARBYCLOR |
| Generic / active ingredient | CHLORTHALIDONE : 12.5 MG AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) : 80 MG |
| Manufacturer | BAUSCH HEALTH, CANADA INC. |
| Strength | 12.5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C09DA09 AZILSARTANT MEDOXIMIL AND DIURETICS |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 13-Jul-2021 |
What can be used instead?
Other Canadian products sharing ATC code C09DA09 AZILSARTANT MEDOXIMIL AND DIURETICS. 2 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| EDARBYCLOR | 12.5 MG | TABLET | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02397749 |
| EDARBYCLOR | 40 MG | TABLET | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02397765 |
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.